Beth Rosenshein
Beth Rosenshein is an electrical/bio-medical engineer and is very familiar with medical research. She holds two United States patents, one for a unique design of a vaginal speculum, and one for a clever urinary collection device specifically designed for women. Beth discovered and documented an important drug interaction between esomeprazole (Nexium) and testosterone. Her findings were published in a case study in The American Journal of the Medical Sciences in May 2004. She petitioned the FDA in August 2003 to change the labeling on hormone products. The petition was granted in September 2004. Beth is also a wife and mother and lives in Boulder, Colorado.
Hometown: Boulder, CO United States
Occupation: Author/Researcher
Website: http://www.diamondrf.org/
Interests: Find effective, science based treatments, for menopause.
Created Diamond Research Foundation to find ways to seamlessly transition from ovarian failure (menopause) to Ovarian Replacement Therapy (ORT) thereby skipping hypogonadism completely.
Created Diamond Research Foundation to find ways to seamlessly transition from ovarian failure (menopause) to Ovarian Replacement Therapy (ORT) thereby skipping hypogonadism completely.
Posts
5 Experts Who Are Wrong On Menopause
Recently 5 menopause experts from different universities from the United States and Canada were asked the following question:Is hormone replacement therapy safe?Their answers prove they are no experts.Not one doctor acknowledged menopause as a disease. By definition, disease is defined by predict...
Orgasm Without Sexual Sensation
An orgasm without sexual sensation is not as uncommon as you would think. If you normally have, or have had, normal sexual response and then you find that you feel the vibrations of an orgasm without the intense pleasure, then you have had an orgasm without sexual sensation. It is often called se...
Discrimination in the KEEPS trial, Part 4 of 5
The discrimination in the KEEPS trial is very real and very damaging to the clinician's and patient's ability to receive appropriate care of advanced/profound hypogonadism (untreated menopause). The KEEPS clinical trial uses archaic and uncomfortable methods, ignores modern technology and misrepr...
Discrimination in the KEEPS trial - Part 5 of 5
In my final installment of my 5 part series describing the discrimination in the KEEPS trial I will discuss what the future holds for the treatment of profound/advanced hypogonadism in women if trials like the KEEPS trial remain the norm.Unless something changes then the future will be as bleak a...
Discrimination in the KEEPS trial - Part 3 of 5
To recap from parts 1 and 2: The KEEPS trial is one of two hormone trials out of the Kronos Longevity Research Institute. One trial is for men and one is for women, both for the same condition, low hormones. The difference is that discrimination is designed into the women's clinical trial. The di...
Goals
Travel the world (590 followers)